Literature DB >> 25772244

Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells.

Y-H Fan1,2, J Ding3,4, S Nguyen1, X-J Liu3, G Xu3, H-Y Zhou3, N-N Duan3, S-M Yang2, M A Zern1,5, J Wu1,3,5,6,7.   

Abstract

Hepatoma exhibits a series of heterogeneous subpopulations in its cell surface markers, tumorigenicity, invasion and metastatic capability. We previously demonstrated that the CD133(-)/EpCAM(-) hepatoma subpopulation was more metastatic than its counterpart; however, the controlling mechanisms are unexplored. The present study aimed to delineate the significance of aberrant hedgehog (Hh) signaling in the mediation of metastases. Fluorescence-activated cell sorting-enriched CD133(-)/EpCAM(-) (double negative, DN), Huh-7 cells underwent a transwell selection for metastatic cells (transwell-selected, TS). The TS cells displayed much greater metastatic activity as evidenced by an increased invasion rate, extremely upregulated expression of matrix metalloproteinase (MMP)-1/2/9 genes compared with DN and double-positive (DP) subpopulations. In contrast to DP cells, TS cells lost E-cadherin and were all vimentin-positive as shown by immunocytochemistry. There was a transitional increase in Gli-1/2 gene expression levels from DP, DN to TS subpopulations, which was consistent with elevated Gli-1/2 or Twist-1 protein levels in the nuclear fraction. Furthermore, truncated Gli-1 (tGli-1), which transactivates molecules involved in metastasis, was detected in the highly invasive Huh-7 cell subpopulation, but not in less metastatic hepatoma cells or normal hepatocytes. The enhanced metastatic features with increased expression of MMPs as well as the presence of twist and snail genes in TS Huh-7 cells were reversed by LDE225, a potent Smoothened antagonist. In conclusion, the highly metastatic capability of a unique TS subpopulation was highly attributed to significant epithelial-mesenchymal transition, enhanced Hh activity and aberrant occurrence of a tGli-1 variant, which appears to be responsible for the highly invasive behavior.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25772244     DOI: 10.1038/onc.2015.67

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  The GLI gene encodes a nuclear protein which binds specific sequences in the human genome.

Authors:  K W Kinzler; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

2.  Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.

Authors:  Nan You; Weihui Liu; Tao Wang; Ru Ji; Xing Wang; Zhenbing Gong; Kefeng Dou; Kaishan Tao
Journal:  Oncol Rep       Date:  2012-09-17       Impact factor: 3.906

Review 3.  Generation of phenotypic diversity and progression in metastatic tumor cells.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

4.  Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver.

Authors:  L Liu; M A Zern; M E Lizarzaburu; M H Nantz; J Wu
Journal:  Gene Ther       Date:  2003-01       Impact factor: 5.250

Review 5.  Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review).

Authors:  Yuriko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2008-09       Impact factor: 4.101

Review 6.  Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.

Authors:  Y Katoh; M Katoh
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

7.  Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice.

Authors:  Jian Wu; Li Liu; Roy D Yen; Andreea Catana; Michael H Nantz; Mark A Zern
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

10.  Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.

Authors:  X Cao; J Geradts; M W Dewhirst; H-W Lo
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

View more
  15 in total

1.  Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.

Authors:  Tadas K Rimkus; Richard L Carpenter; Sherona Sirkisoon; Dongqin Zhu; Boris C Pasche; Michael D Chan; Glenn J Lesser; Stephen B Tatter; Kounosuke Watabe; Waldemar Debinski; Hui-Wen Lo
Journal:  Cancer Res       Date:  2018-02-20       Impact factor: 12.701

2.  Targeting Hedgehog signalling in CD133-positive hepatocellular carcinoma: improving Lenvatinib therapeutic efficiency.

Authors:  Qingqing Hu; Xiaochu Hu; Lingjian Zhang; Yalei Zhao; Lanjuan Li
Journal:  Med Oncol       Date:  2021-03-17       Impact factor: 3.064

3.  Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.

Authors:  Jia Ding; Xiao-Tian Zhou; Hao-Yu Zou; Jian Wu
Journal:  Lab Invest       Date:  2017-04-17       Impact factor: 5.662

Review 4.  Hedgehog signaling and its molecular perspective with cholesterol: a comprehensive review.

Authors:  Jyoti B Kaushal; Surinder K Batra; Satyanarayana Rachagani
Journal:  Cell Mol Life Sci       Date:  2022-04-29       Impact factor: 9.261

Review 5.  Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.

Authors:  Richard L Carpenter; Haimanti Ray
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

Review 6.  Hedgehog signalling in liver pathophysiology.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  J Hepatol       Date:  2017-10-26       Impact factor: 25.083

7.  Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma.

Authors:  Ana Almazán-Moga; Patricia Zarzosa; Isaac Vidal; Carla Molist; Irina Giralt; Natalia Navarro; Aroa Soriano; Miguel F Segura; Arantza Alfranca; Javier Garcia-Castro; José Sánchez de Toledo; Josep Roma; Soledad Gallego
Journal:  Stem Cells Int       Date:  2017-01-24       Impact factor: 5.443

8.  Preliminary screening and analysis of metastasis-related lncRNA and co-expressed papillary thyroid carcinoma mRNA.

Authors:  Ming-Hua Ge; Lie-Hao Jiang; Qing-Liang Wen; Zhuo Tan; Chao Chen; Chuan-Ming Zheng; Xin Zhu; Jia-Wen Chen; Zi-Yu Zhu; Xiu-Jun Cai
Journal:  Oncol Lett       Date:  2018-07-05       Impact factor: 2.967

9.  Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.

Authors:  Xiao-Tian Zhou; Jia Ding; Hui-Yan Li; Jie-Liang Zuo; Sheng-Yang Ge; Hu-Liang Jia; Jian Wu
Journal:  J Cell Mol Med       Date:  2020-02-28       Impact factor: 5.310

10.  Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells.

Authors:  F Faião-Flores; D K Alves-Fernandes; P C Pennacchi; S Sandri; A L S A Vicente; C Scapulatempo-Neto; V L Vazquez; R M Reis; J Chauhan; C R Goding; K S Smalley; S S Maria-Engler
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.